Clinical Trial Update: Blood Brain Barrier Penetration and Pharmacokinetics of the Elemene in Malignant Patients.

View source ↗

Summary

This clinical trial update reports on the blood-brain barrier penetration and pharmacokinetics of Elemene in malignant patients. The sponsor is Dalian Holley Ki…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Elemene (elemene)

Snippet

Sponsor: Dalian Holley Kingkong Pharmaceutical Co., Ltd | Conditions: Cancer | Status: UNKNOWN